A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split
Farah, R. (2018). A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split (Master's thesis). Split: University of Split, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:171:164339
Farah, Rinata. "A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split." Master's thesis, University of Split, School of Medicine, 2018. https://urn.nsk.hr/urn:nbn:hr:171:164339
Farah, Rinata. "A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split." Master's thesis, University of Split, School of Medicine, 2018. https://urn.nsk.hr/urn:nbn:hr:171:164339
Farah, R. (2018). 'A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split', Master's thesis, University of Split, School of Medicine, accessed 25 December 2024, https://urn.nsk.hr/urn:nbn:hr:171:164339
Farah R. A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split [Master's thesis]. Split: University of Split, School of Medicine; 2018 [cited 2024 December 25] Available at: https://urn.nsk.hr/urn:nbn:hr:171:164339
R. Farah, "A retrospective study comparing abiraterone acetate and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer in Split", Master's thesis, University of Split, School of Medicine, Split, 2018. Available at: https://urn.nsk.hr/urn:nbn:hr:171:164339